The Disease Burden of Hereditary Angioedema: Insights from a Survey in French-Canadians from Quebec

Table 6

Types of LTP treatment used in HAE type I/II compared to HAE nC1-INH.

	HAE type I/II (n = 17), n (%)	HAE nC1-INH (n = 15), n (%)
Treatment(s) you have received as LTP
Tranexamic acid	3 (18%)	9 (60%)
SC C1-INH concentrate	9 (53%)	3 (20%)
IV C1-INH concentrate	7 (41%)	3 (20%)
Other	3 (18%)	0 (0%)

C1-INH, C1 inhibitor; HAE, hereditary angioedema; HAE nC1-INH, hereditary angioedema with normal C1 inhibitor; IV, intravenous; LTP, long-term prophylaxis; SC, subcutaneous.